Drug profile · INN
glycopyrronium
AXHIDROX
glycopyrronium (AXHIDROX) is a muscarinic acetylcholine receptor inhibitor. Associated with Novartis Pharmaceuticals.
EMA: approved TGA: approved NMPA: clinical trials Respiratory system (R03) R03AL07
Patents linked 1
Pipeline programs 6
News articles 0
Drug details — glycopyrronium
- Class
- Respiratory system (R03)
- Route
- —
- Patents
- 1
- Programs
- 6
- Data quality
- 0.83
Quick answer
glycopyrronium (AXHIDROX) is a muscarinic acetylcholine receptor inhibitor. Associated with Novartis Pharmaceuticals.
Key facts
INN glycopyrronium
Brand AXHIDROX
Mechanism Muscarinic acetylcholine receptor inhibitor
Therapeutic class Respiratory system (R03)
ATC code R03AL07
Originator Novartis Pharmaceuticals
Mechanism of action
Muscarinic acetylcholine receptor inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is glycopyrronium?
glycopyrronium (AXHIDROX) is a muscarinic acetylcholine receptor inhibitor. Associated with Novartis Pharmaceuticals.
What is the brand name for glycopyrronium?
AXHIDROX is a marketed brand name for glycopyrronium. Check FDA Drugs@FDA for the current US label holder and prescribing information.